Study shows lasting T-cell immunity in healthcare workers against SARS-CoV-2 variants

Study reveals robust memory T-cell responses to SARS-CoV-2 in healthcare workers over 1.5 years post-Omicron, suggesting durable immunity against highly mutated variants.

Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment – Biotech Investments

EQS-News: Affluent Medical SA / Key word(s): Agreement Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment 12.07.2024 / 07:45 CET/CEST

July 13, 2024

FDA advisers endorse updating Covid vaccines to target latest Omicron strain

The Covid-19 vaccines are on track for a big recipe change this fall. Today’s vaccines still contain the original coronavirus strain, the one that started

June 15, 2023

Eli Lilly settles with medical spa over its marketing of compounded tirzepatide

Eli Lilly reached a settlement with a South Carolina medical spa, marking a win in a broader legal campaign against how compounders have marketed versions

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.